BioMarin Pharmaceutical, Inc. (BMRN)

64.30 +0.22 (+0.34%) USD  |  NASDAQ  |  Feb 23, 12:51
More

BioMarin Pharmaceutical Ending Cash (Quarterly)

Ending Cash (Quarterly) Chart

View Ending Cash (Quarterly) for BMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Ending Cash (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Ending Cash (Quarterly) Range, Past 5 Years

View Ending Cash (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Ending Cash (Quarterly) Benchmarks

View Ending Cash (Quarterly) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Gilead Sciences, Inc. --
Merck & Co., Inc. --
AbbVie, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade